Can a new injection help tame asthma? a trial seeks answers

NCT ID NCT07732023

Not yet recruiting Disease control Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests an experimental drug called SKB575 in adults with asthma. The goal is to see if it is safe and whether it can improve asthma control and lung function. Participants receive either SKB575 or a placebo as a shot under the skin, and researchers monitor side effects and breathing tests over several weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an experimental drug called SKB575 (also known as HBM7575) given as a shot under the skin
What this could lead to: If it works, this could point toward a new treatment option for people with asthma that helps control symptoms and improve breathing.
What could go wrong: This is an early phase 1b trial with only 36 participants, so it is primarily testing safety. The drug may not improve asthma control or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA (DIAGNOSIS)

Contacts and locations

Locations

West China Hospital of Sichuan University

Chengdu, Sichuan, 610044, China
West China Hospital of Sichuan University

Chengdu, Sichuan, 610044, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.